Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions
Seminars in Cancer Biology · 2025
DOI: 10.1016/j.semcancer.2025.01.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025. Verfasst von Huatao Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha 410011, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Immunosenescence. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 350 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Xiangya Hospital, Central South University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Non-small cell lung cancer (NSCLC), the most prevalent form of lung cancer, remains a leading cause of cancer-related mortality worldwide, particularly among elderly individuals. The phenomenon of immunosenescence, characterized by the progressive decline in immune cell functionality with aging, plays a pivotal role in NSCLC progression and contributes to the diminished efficacy of therapeutic interventions in older patients. Immunosenescence manifests through impaired immune surveillance, reduced cytotoxic responses, and increased chronic inflammation, collectively fostering a pro-tumorigenic microenvironment. This review provides a comprehensive analysis of the molecular, cellular, and genetic mechanisms of immunosenescence and its impact on immune surveillance and the tumor microenvironment (TME) in NSCLC. We explore how aging affects various immune cells, including T cells, B cells, NK cells, and macrophages, and how these changes compromise the immune system's ability to detect and eliminate tumor cells. Furthermore, we address the challenges posed by immunosenescence to current therapeutic strategies, particularly immunotherapy, which faces significant hurdles in elderly patients due to immune dysfunction. The review highlights emerging technologies, such as single-cell sequencing and CRISPR-Cas9, which offer new insights into immunosenescence and its potential as a therapeutic target. Finally, we outline future research directions, including strategies for rejuvenating the aging immune system and optimizing immunotherapy for older NSCLC patients, with the goal of improving treatment efficacy and survival outcomes. These efforts hold promise for the development of more effective, personalized therapies for elderly patients with NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha 410011, China.
- Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha 410011, China. Electronic address: fanchengming@csu.edu.cn.
- Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Middle Renmin Road 139, Changsha 410011, China. Electronic address: zhouzijing1114@csu.edu.cn.
Förderung
- Natural Science Foundation of Hunan Province
- Xiangya Hospital, Central South University
- National Natural Science Foundation of China
Zitieren
APA
Zhou, H., Zheng, Z., Fan, C., & Zhou, Z. (2025). Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2025.01.001
Vancouver
Zhou H, Zheng Z, Fan C, Zhou Z. Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions. Seminars in Cancer Biology. 2025. doi:10.1016/j.semcancer.2025.01.001
BibTeX
@article{Zhou2025,
author = {Zhou, Huatao and Zheng, Zilong and Fan, Chengming and Zhou, Zijing},
title = {Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions},
journal = {Seminars in Cancer Biology},
year = {2025},
doi = {10.1016/j.semcancer.2025.01.001}
}
EUVIMED